# US 2020/0002441 A1 · Method of crosslinking glycosaminoglycans

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002441 A1
- Document ID: US20200002441A1
- Status: Published application
- Kind: A1
- Application number: 16/322,653
- Filed: 2017-08-02
- Published: 2020-01-02
- Earliest claimed: 2016-08-03
- Assignees: Galderma Research & Development; Centre National De La Recherche Scientifique
- Applicants: Galderma Research & Development; Centre National De La Recherche Scientifique
- Inventors: Rachel AUZELY-VELTY; Tamiris FIGUEIREDO; Laura JING JING; Craig Steven HARRIS; Jean-Guy BOITEAU; Thibaut GERFAUD; Loic TOMAS
- Web page: https://patentgrep.com/patent/US20200002441A1

## CPC

- A61K 8/042: {Gels}
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61Q 19/08: Anti-ageing preparations
- C08B 37/0063: {Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A new hydrogel made of double crosslinked glycosaminoglycans, particularly crosslinked hyaluronic acid, chondroitin or chondroitin sulfate, having reversible linkages using boronic acid or boroxole derivatives leading to new benefits. Double crosslinked glycosaminoglycans, one linkage via two ether bonds with a hydroxyl group of each of two glycosaminoglycans and another linkage via an alkoxyboronate ester anion formed between a boronate hemiester grafted to one of the glycosaminoglycans and a diol function of to the other glycosaminoglycan. The diol function may be a backbone diol function or a diol portion of a diol functional moiety grafted the other glycosaminoglycan.

## Claims

### Claim at position 1

1-51. (canceled)

### Claim 52

Glycosaminoglycans crosslinked by a first and a second linkage, wherein
a) said first linkage comprises two ether bonds, one bond formed with a hydroxyl group of each of a first glycosaminoglycan and a second glycosaminoglycan; and
b) said second linkage is via an alkoxyboronate ester anion formed between a boronate hemiester grafted to the first glycosaminoglycan and a diol function of the second glycosaminoglycan,
wherein said diol function may be a backbone diol function or a diol portion of a diol functional moiety grafted to said second glycosaminoglycan.

### Claim 53 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, wherein said second linkage is defined in Formula (I)
wherein
R1 is selected from H, F, Cl, NO2, C1-C3alkyl, C1-C3haloalkyl and C1-C3alkoxy;
R2, R3 and R4 are independently selected from H, F, Cl, C1-C3haloalkyl, NO2, C1-C3alkoxy, C1-C3alkyl and a linker, said linker binding covalently to said first glycosaminoglycan;
X is selected from CHR7 and a bond;
R5, R6 and R7 are independently selected from H, C1-C4alkyl, C3-C6cycloalkyl, phenyl, and a five- to six-membered heteroaromatic ring comprising 1 to 3 heteroatoms selected from O, N and S; and
wherein one of R2, R3 and R4 is a linker.

### Claim 54 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, wherein said glycosaminoglycans are hyaluronic acid.

### Claim 55 (depends on 53)

Crosslinked glycosaminoglycans according to claim 53, wherein R2 is a linker.

### Claim 56 (depends on 53)

Crosslinked glycosaminoglycans according to claim 53, wherein said linker is
—NR9—Y— and forms an amide bond with said first glycosaminoglycans, wherein R9 is selected from hydrogen, C1-C3alkyl and C1-C3fluoroalkyl; and
Y is a bond or an unsubstituted C1-C6alkylene.

### Claim 57 (depends on 53)

Crosslinked glycosaminoglycans according to claim 53, wherein
R1, R3 and R4 are independently selected from H, F, OCH3, CF3 and CH3;
R2 is a linker;
said linker is —HN—Y— and forms an amide bond with said first glycosaminoglycan;
Y is a bond or an unsubstituted C1-C3alkylene;
X is a bond or CH2; and
R5 and R6 are independently selected from H and C1-C3alkyl.

### Claim 58 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, wherein said boronate hemiester is selected from
wherein the boronate hemiester is grafted to said first glycosaminoglycan by that the —NH2 group of the boronate hemiester forms an amide with a backbone carboxylate group of said first glycosaminoglycan.

### Claim 59 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, said second linkage having a structure of Formula (II)

### Claim 60 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, wherein said diol function is a backbone diol function.

### Claim 61 (depends on 52)

Crosslinked glycosaminoglycans according to claim 52, wherein said diol function is a diol portion of a diol functional moiety grafted to said second glycosaminoglycan,
wherein said diol portion is selected from a monosaccharide, a disaccharide and an alditol or a derivative thereof, or wherein said diol portion is selected from maltose, fructose, lactose and sorbitol or a derivative thereof.

### Claim 62

A method of crosslinking glycosaminoglycans, comprising the steps of:
forming a linkage comprising two ether bonds, one bond formed with a hydroxyl group of each a first and a second glycosaminoglycan;
grafting said first glycosaminoglycan with a boronate hemiester and crosslinking said first glycosaminoglycan with said second glycosaminoglycan by forming an alkoxyboronate ester anion linkage between the boronate hemiester of said first glycosaminoglycan and a diol function of said second glycosaminoglycan, wherein said diol function may be a backbone diol function or a diol portion of a diol functional moiety grafted to said second glycosaminoglycan.

### Claim 63 (depends on 62)

A method according to claim 62, wherein said boronate hemiester is a compound of Formula (III),
wherein
R1 is selected from H, F, Cl, NO2, C1-C3alkyl, C1-C3haloalkyl and C1-C3alkoxy;
R2, R3 and R4 are independently selected from H, F, Cl, C1-C3haloalkyl, NO2, C1-C3alkoxy, C1-C3alkyl and a linker binding covalently to said first glycosaminoglycan;
X is selected from CHR7 and a bond; and
R5, R6 and R7 are independently selected from H, C1-C4alkyl, C3-C6cycloalkyl, phenyl, and a five- to six-membered heteroaromatic ring comprising 1 to 3 heteroatoms selected from O, N and S,
wherein one of R2, R3 and R4 is a linker.

### Claim 64 (depends on 62)

A method according to claim 62, wherein said first and said second glycosaminoglycans are hyaluronic acid.

### Claim 65 (depends on 63)

A method according to claim 63, wherein R2 is a linker.

### Claim 66 (depends on 63)

A method according to claim 63, wherein said linker is HR9N—Y— and forms an amide bond with said first glycosaminoglycan, wherein R9 is selected from hydrogen, C1-C3alkyl and C1-C3fluoroalkyl; and
Y is a bond or an unsubstituted C1-C6alkylene.

### Claim 67 (depends on 63)

A method according to claim 63, wherein
R1, R3 and R4 are independently selected from H, F, OCH3, CF3 and CH3;
R2 is a linker;
said linker is H2N—Y— and forms an amide bond with said first glycosaminoglycan;
Y is a bond or an unsubstituted C1-C3alkylene;
X is a bond or CH2; and
R5 and R6 are independently selected from H and C1-C3alkyl.

### Claim 68 (depends on 62)

A method according to claim 62, wherein said boronate hemiester is selected from
wherein the boronate hemiester is grafted to said first glycosaminoglycan by that the —NH2 group of the boronate hemiester forms an amide with a backbone carboxylate group of said first glycosaminoglycan.

### Claim 69 (depends on 62)

A method according to claim 62, wherein said diol function is a backbone diol function.

### Claim 70 (depends on 62)

A method according to claim 62, wherein said diol function is a diol portion of a diol functional moiety grafted to said second glycosaminoglycan,
wherein said diol portion is selected from a monosaccharide, a disaccharide and an alditol or a derivative thereof, or selected from maltose, fructose, lactose and sorbitol or a derivative thereof.

### Claim 71 (depends on 52)

Polymer composition comprising crosslinked glycosaminoglycans according to claims 52 and an aqueous buffer.
